Six Studies on Saffron Put Prozac to Shame for Depression and OCD
What if a common, affordable spice worked as well or better than antidepressants for mood disorders and anxiety–minus the dangerous side effects? Emerging research on saffron challenges pharmaceutical dominance over psychiatry
Modern psychiatry relies heavily on selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac) for conditions like depression and obsessive-compulsive disorder (OCD).
But groundbreaking studies show the ancient herbal remedy saffron (Crocus sativus) matches or exceeds synthetic drugs for efficacy, with greater safety and bonus health benefits.
A 2016 double-blind trial tested 30mg daily saffron versus 40mg fluoxetine in women with postpartum depression over 6 weeks.1 Saffron performed on par with the blockbuster drug.
Over 40 percent of saffron patients saw a 50 percent+ reduction in symptoms versus 50 percent of fluoxetine patients – no significant difference. Adverse events were also similar between groups.
In an 8-week study of mild-moderate OCD, 60 patients took either 30mg saffron or 40mg fluoxetine daily.2 Saffron again matched the SSRI drug, with significant improvements in Yale–Brown Obsessive Compulsive Scale scores in both groups. Saffron patients also experienced many fewer adverse effects.
Two additional clinical trials found the same daily saffron doses WORKED as well as higher-dose fluoxetine (60mg daily) over 8-12 weeks for both mild-severe major depressive disorder3 and panic disorder.4
No differences emerged in efficacy between the herbal remedy and pharmaceutical products containing double the drugs by weight.
Finally, a small but high-quality 2020 study compared 8 weeks of standardized 15mg saffron versus 10mg escitalopram oxalate (Lexapro) for 54 patients with major depression.5
Saffron showed significantly greater reductions in Hamilton Depression scores and response/remission rates versus the blockbuster SSRI. Lexapro performs as one of the most potent antidepressants among SSRIs.
Unlike Drugs, Saffron Offers Bonus Health Benefits
Given the clinical promise demonstrated, saffron’s exceptional safety offers a key benefit over antidepressants. Common SSRI drug harms include nausea, diarrhea, dizziness, agitation, insomnia, loss of sexual function,7 and increased suicidal thoughts in young people.6
Saffron trials overall found no meaningful difference from placebo in adverse event frequency at effective doses.1-5 As an antioxidant and anti-inflammatory, mounting research actually suggests supplemental saffron likely provides diverse health protection effects against chronic diseases.8
No psychiatric medications offer similar value-adding virtues.
Emerging evidence indicates saffron provides a viable phytopharmaceutical alternative for various mood, anxiety, and obsessive-compulsive disorders.
Well-controlled trials find specific standardized extracts compare favorably to classic SSRI drugs for efficacy and safety.
Combined with low cost, nutrient value, and a wide therapeutic window, the case for saffron over pharmaceuticals in mental health care keeps growing.
See more here substack.com
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
Lorraine
| #
“I’m just mad about saffron, saffron’s mad about me.
They call me mellow yellow, quite rightly.”
Donovan was onto something, eh?
Natural psychedelic herbal remedies are the new/old thing.
Reply
Seriously
| #
Affordable spice??? Clearly has no clue what this stuff costs!!!
Reply